title: [Hepatorenal syndrome. Cases report].
abstract: The hepatorenal syndrome is defined as renal failure in patients with severe liver disease. It may be diagnosed by exclusion of other potential factors which may cause renal failure, such as hypovolaemia, nephrotoxic drugs and severe bacterial infection. Liver transplantation is the target treatment leading to recovery of renal function. Other methods such as vasoconstrictors, renal replacement therapy and repeated paracenthesis with intravenous albumin infusions are also presented.
authors.affiliation: Oddzial Chorób Wewnetrznych ze Stacja Dializ SZPOZ w Wolominie. s.niemczyk@gazeta.pl
authors.forename: Stanisław
authors.initials: S
authors.lastname: Niemczyk
authors.forename: Katarzyna
authors.initials: K
authors.lastname: Romejko-Ciepielewska
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Gomółka
authors.forename: Agata
authors.initials: A
authors.lastname: Skorupińska
authors.forename: Paweł
authors.initials: P
authors.lastname: Kulicki
authors.forename: Michał
authors.initials: M
authors.lastname: Pyrza
authors.forename: Joanna
authors.initials: J
authors.lastname: Matuszkiewicz-Rowińska
mesh_terms: D000328:Adult; D006519:Hepatitis, Alcoholic / Q000150:complications* / Q000628:therapy; D006530:Hepatorenal Syndrome / Q000209:etiology* / Q000628:therapy*; D006801:Humans; D008104:Liver Cirrhosis, Alcoholic / Q000150:complications* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D012076:Renal Agents / Q000627:therapeutic use; D017582:Renal Replacement Therapy / Q000379:methods; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
chemical_list: D012076:Renal Agents; D014662:Vasoconstrictor Agents